Global Neuromodulation Devices and Implantable Infusion Pumps Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
According to our (Global Info Research) latest study, the global Neuromodulation Devices and Implantable Infusion Pumps market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent. 
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.
This report is a detailed and comprehensive analysis for global Neuromodulation Devices and Implantable Infusion Pumps market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2018-2029
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2018-2029
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2018-2029
Global Neuromodulation Devices and Implantable Infusion Pumps market shares of main players, shipments in revenue ($ Million), sales quantity (Unit), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neuromodulation Devices and Implantable Infusion Pumps
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neuromodulation Devices and Implantable Infusion Pumps market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical and Nevro Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Neuromodulation Devices and Implantable Infusion Pumps market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Spinal Cord Stimulation
    Deep Brain Stimulation
    Sacral Nerve Stimulation
    Vagal Nerve Stimulation
    Gastric Stimulation
    Transcranial Magnetic Stimulation
    Transcutaneous Electrical Stimulation
    Other
Market segment by Application
    Parkinson's Disease
    Epilepsy
    Pain
    Other
Major players covered
    Medtronic
    Boston Scientific Corporation
    St. Jude Medical
    Synapse Biomedical
    Nevro Corporation
    Neuropace
    Cyberonics
    Autonomic Technologies
    Avery Biomedical
    Greatbatch Medical
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuromodulation Devices and Implantable Infusion Pumps product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, with price, sales, revenue and global market share of Neuromodulation Devices and Implantable Infusion Pumps from 2018 to 2023.
Chapter 3, the Neuromodulation Devices and Implantable Infusion Pumps competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuromodulation Devices and Implantable Infusion Pumps breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Neuromodulation Devices and Implantable Infusion Pumps market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neuromodulation Devices and Implantable Infusion Pumps.
Chapter 14 and 15, to describe Neuromodulation Devices and Implantable Infusion Pumps sales channel, distributors, customers, research findings and conclusion.